Turing Biosystems
London
About Turing Biosystems
Turing Biosystems concentrates on the problems of severe toxicities and elevated failure rates in immunotherapy, cell, and gene therapy. The platform is based on a revolutionary interpretable AI that uses automated reasoning and current technology. Their platform integrates all accessible multimodal data and details on a patient or cohort, including metadata, medical records, and other data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Seed (Oct 2024)
- Website: turing.bio
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/turing-biosystems-37253 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.